The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution

BACKGROUND: Synovial sarcoma (SS) is a highly aggressive soft-tissue sarcoma (STS) with poor prognosis. Tyrosine kinase inhibitor (TKI) has shown a promising impact on advanced STS patients. This study aimed to evaluate the efficacy and safety of apatinib, an oral multi-TKI, which especially inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yitian, Lu, Minxun, Zhou, Yong, Zhou, Sisi, Yu, Xinzhu, Tang, Fan, Luo, Yi, Zhang, Wenli, Duan, Hong, Min, Li, Tu, Chongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335867/
https://www.ncbi.nlm.nih.gov/pubmed/32669874
http://dx.doi.org/10.2147/CMAR.S254296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335867/
https://www.ncbi.nlm.nih.gov/pubmed/32669874
http://dx.doi.org/10.2147/CMAR.S254296

Ejemplares similares